Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea

BACKGROUND: Osteoporosis is a progressive skeletal disease associated with an increased risk of bone fracture. This study aimed to estimate the cost-effectiveness of denosumab for osteoporotic fracture prevention compared to bisphosphonates (alendronate, ibandronate, risedronate, and zoledronate) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Jung-Yoon, Choi, Leejung, Johnson, Ben, Yang, Hyowon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208907/
https://www.ncbi.nlm.nih.gov/pubmed/35718925
http://dx.doi.org/10.11005/jbm.2022.29.2.83

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208907/
https://www.ncbi.nlm.nih.gov/pubmed/35718925
http://dx.doi.org/10.11005/jbm.2022.29.2.83

Ejemplares similares